Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Comparing Elevance Health (ELV) and Molina Healthcare (MOH): Diversification Against Concentration

Comparing Elevance Health (ELV) and Molina Healthcare (MOH): Diversification Against Concentration

Key Takeaways

  • ELV is a larger, more diversified health benefits company, while MOH is a Medicaid-focused managed care operator with a smaller, more concentrated footprint.
  • Elevance Health raised its 2026 adjusted earnings guidance in recent weeks and trades near its 52-week high, reflecting stronger recent earnings momentum.
  • Molina Healthcare is positioned as a Medicaid margin-recovery story, but its medical cost ratio (MCR) remains elevated and its membership base has contracted.
  • Tickeron AI Verdict: ELV is the favored ticker based on trend consistency, diversification, and relative stability.
  • For deeper coverage of each name, explore ELV Major News and ELV Today's Price Move, as well as MOH Major News and MOH Today's Price Move.
  • To see which strategies are currently in focus, explore Trending AI Robots.

Introduction

Investors following the managed care space often compare large, diversified insurers with smaller, specialized operators. This analysis looks at ELV (Elevance Health) and MOH (Molina Healthcare), two names with exposure to government-sponsored programs yet very different scales, business mixes, and market positions. The comparison matters for those assessing relative performance in health insurance and weighing risk tolerance, growth drivers, and sensitivity to Medicaid and Medicare policy shifts.

Elevance Health Overview and Recent Performance

Elevance Health, formerly Anthem, runs one of the largest health benefits platforms in the United States, serving roughly 104 million consumers through its Health Benefits segment and Carelon services division, which includes CarelonRx pharmacy benefit manager and Carelon Services. Shares have shown notable strength lately, trading near 52-week highs after stronger-than-expected third-quarter results. Adjusted EPS grew about 16% year over year, and the company lifted its 2026 adjusted EPS outlook to at least $29. Management views 2026 as the trough for Medicaid margins, with improvement expected in 2027, while Carelon adds diversified services-based growth. As a dividend payer with a broad commercial book, ELV presents a relatively balanced profile. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Molina Healthcare Overview and Recent Performance

Molina Healthcare focuses mainly on Medicaid, with additional Medicare and Marketplace segments, serving about 4.9 million members. The stock has recovered sharply from early-year lows after a tough fourth quarter of 2025. Third-quarter results beat estimates on revenue and adjusted EPS, though revenue declined year over year and membership contracted amid Medicaid redeterminations. The medical care ratio stayed elevated near 93%, and management sees current Medicaid margins as the likely trough of a multi-year cycle. MOH pays no dividend and remains more concentrated in government programs, increasing its sensitivity to rate and policy changes.

Head-to-Head Comparison

The clearest difference lies in diversification versus concentration. ELV covers commercial, Medicaid, Medicare, and a growing services arm, helping cushion earnings against pressure in any one program. MOH, by contrast, draws most revenue from Medicaid, offering greater upside from a rate recovery but also higher exposure to membership shifts and utilization trends. On momentum, ELV has shown steadier trend strength with raised guidance and a climb toward multi-month highs, while MOH posted larger percentage gains from a lower base amid thinner margins. Risk profiles differ too: ELV carries a dividend and more defensive balance sheet, whereas MOH faces greater execution risk around new contracts and eligibility changes.

Tickeron AI Verdict

Based on trend consistency, earnings momentum, business diversification, and relative stability, Tickeron’s AI currently favors ELV over MOH. Elevance Health’s raised guidance, services-driven growth, and steady advance suggest a more durable trend, while Molina Healthcare’s recovery hinges more on Medicaid rate realization and margin inflection. This remains a probabilistic view of relative positioning rather than a firm forecast, and conditions could shift the balance.

Using AI Tools for Ongoing Research

When evaluating names like these, I often turn to Tickeron’s Trending AI Robots page to review automated strategies suited to current market conditions. The section curates bots from a larger library, each with its own style, timeframe, and performance data, helping provide additional context on technical and sentiment signals without replacing fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MOH, ELV

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MOH in upward trend: price rose above 50-day moving average on October 30, 2026

MOH moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 52 cases where MOH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on MOH as a result. In 56 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for MOH just turned positive on November 16, 2026. Looking at past instances where MOH's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.

The 10-day moving average for MOH crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOH advanced for three days, in 215 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 149 of 222 cases where MOH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

MOH broke above its upper Bollinger Band on November 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating fairly steady price growth. MOH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.616) is normal, around the industry mean (3.520). MOH's P/E Ratio (1306.188) is considerably higher than the industry average of (126.353). Projected Growth (PEG Ratio) (0.880) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.233) is also within normal values, averaging (0.569).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 67.69B. The market cap for tickers in the group ranges from 335.99K to 353.79B. UNH holds the highest valuation in this group at 353.79B. The lowest valued company is IHGP at 335.99K.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 5%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 18%. MOH experienced the highest price growth at 15%, while OSCR experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was 17% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 44
Price Growth Rating: 37
SMR Rating: 72
Profit Risk Rating: 82
Seasonality Score: 4 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of health care services to persons eligible for Medicaid

Industry ManagedHealthCare

Industry
Managed Health Care
Address
200 Oceangate
Phone
+1 562 435-3666
Employees
19000
Web
https://www.molinahealthcare.com
Interact to see
Advertisement
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.
Micron shares fell -6.28% to $729.40 from Friday's $778.31 close, gapping lower in premarket trading and holding those losses into Monday's regular session. The decline was sector-driven, not company-specific: memory peers SanDisk, SK hynix and Western Digital slid in tandem as last week's Nvidia CEO departure revived doubts over AI data-center spending, financing and memory demand durability.
Comparing Elevance Health (ELV) and Molina Healthcare (MOH): Diversification Against Concentration